These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8039240)

  • 1. Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, phagocytosis, and L-arginine.
    Brummer E; Stevens DA
    Cell Immunol; 1994 Aug; 157(1):1-10. PubMed ID: 8039240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of macrophage anticryptococcal activity in vitro is dependent on endogenous M-CSF.
    Brummer E; Gilmore GL; Shadduck RK; Stevens DA
    Cell Immunol; 1998 Nov; 189(2):144-8. PubMed ID: 9790728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-mediated fungistasis: requirement for a macromolecular component in serum.
    Granger DL; Perfect JR; Durack DT
    J Immunol; 1986 Jul; 137(2):693-701. PubMed ID: 3522734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcus neoformans inhibits nitric oxide production by murine peritoneal macrophages stimulated with interferon-gamma and lipopolysaccharide.
    Kawakami K; Zhang T; Qureshi MH; Saito A
    Cell Immunol; 1997 Aug; 180(1):47-54. PubMed ID: 9316638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity.
    Granger DL; Perfect JR; Durack DT
    J Immunol; 1986 Jan; 136(2):672-80. PubMed ID: 3510251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis.
    Dromer F; Perronne C; Barge J; Vilde JL; Yeni P
    Clin Exp Immunol; 1989 Dec; 78(3):412-7. PubMed ID: 2612053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage colony-stimulating factor induction of enhanced macrophage anticryptococcal activity: synergy with fluconazole for killing.
    Brummer E; Stevens DA
    J Infect Dis; 1994 Jul; 170(1):173-9. PubMed ID: 8014494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.
    Flesch IE; Schwamberger G; Kaufmann SH
    J Immunol; 1989 May; 142(9):3219-24. PubMed ID: 2496162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate.
    Cameron ML; Granger DL; Weinberg JB; Kozumbo WJ; Koren HS
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1313-9. PubMed ID: 2123614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.
    Granger DL; Hibbs JB; Perfect JR; Durack DT
    J Clin Invest; 1988 Apr; 81(4):1129-36. PubMed ID: 3280600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological basis for susceptibility and resistance to pulmonary blastomycosis in mouse strains.
    Brummer E; Kethineni N; Stevens DA
    Cytokine; 2005 Oct; 32(1):12-9. PubMed ID: 16183299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18.
    Kawakami K; Qureshi MH; Koguchi Y; Zhang T; Okamura H; Kurimoto M; Saito A
    Cell Immunol; 1999 Apr; 193(1):9-16. PubMed ID: 10202108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous C1q reconstitutes a secondary deficiency of C5-deficient AKR mouse macrophages for FcR-dependent cellular cytotoxicity and phagocytosis.
    Leu RW; Zhou AQ; Kennedy MJ; Shannon BJ
    J Immunol; 1991 Feb; 146(4):1233-9. PubMed ID: 1991965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclic strain on the morphology and phagocytosis of macrophages.
    Miyazaki H; Hayashi K
    Biomed Mater Eng; 2001; 11(4):301-9. PubMed ID: 11790862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.
    Granger DL; Hibbs JB; Perfect JR; Durack DT
    J Clin Invest; 1990 Jan; 85(1):264-73. PubMed ID: 2404026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
    Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
    J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
    Bolaños B; Mitchell TG
    J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum.
    Li RK; Mitchell TG
    J Med Vet Mycol; 1997; 35(5):327-34. PubMed ID: 9402525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
    Sato K; Tomioka H; Saito H
    Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.
    Cross CE; Collins HL; Bancroft GJ
    Immunology; 1997 Jun; 91(2):289-96. PubMed ID: 9227330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.